Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer von Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E, Chow, Laura Q M, Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E, Czyzewicz, Grzegorz, Spigel, David R, Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie

Volltext

L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer von Sangha, Randeep, Butts, Charles

Volltext

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials von Di Maio, Massimo, Gallo, Ciro, Leighl, Natasha B, Piccirillo, Maria Carmela, Daniele, Gennaro, Nuzzo, Francesco, Gridelli, Cesare, Gebbia, Vittorio, Ciardiello, Fortunato, De Placido, Sabino, Ceribelli, Anna, Favaretto, Adolfo G, de Matteis, Andrea, Feld, Ronald, Butts, Charles, Bryce, Jane, Signoriello, Simona, Morabito, Alessandro, Rocco, Gaetano, Perrone, Francesco

Volltext

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of J... von BUTTS, Charles A, KEYUE DING, CORMIER, Yvon, GOSS, Glenwood, FINDLAY, Brian, JOHNSTON, Michael, TSAO, Ming-Sound, SHEPHERD, Frances A, SEYMOUR, Lesley, TWUMASI-ANKRAH, Philip, GRAHAM, Barbara, GANDARA, David, JOHNSON, David H, KESLER, Kenneth A, GREEN, Mark, VINCENT, Mark

Volltext

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study von GOSS, Glenwood D, O'CALLAGHAN, Chris, PISTERS, Katherine, GANDARA, David, KERNSTINE, Kemp, BUTTS, Charles, NOBLE, Jonathan, HENSING, Thomas A, ROWLAND, Kendrith, SCHILLER, Joan, KEYUE DING, SHEPHERD, Frances A, LORIMER, Ian, TSAO, Ming-Sound, MASTERS, Gregory A, JETT, James, EDELMAN, Martin J, LILENBAUM, Rogerio, CHOY, Hak, KHURI, Fadlo

Volltext

VeriStrat validated in patients with non-small-cell lung cancer von Butts, Charles A

Volltext

Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity von PRADO, Carla M. M, BARACOS, Vickie E, MCCARGAR, Linda J, MOURTZAKIS, Marina, MULDER, Karen E, REIMAN, Tony, BUTTS, Charles A, SCARFE, Andrew G, SAWYER, Michael B

Volltext

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

TIME for a successful cancer vaccine in NSCLC? von Butts, Charles A, Sangha, Randeep

Volltext

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial von GRIDELLI, Cesare, CIARDIELLO, Fortunato, LEIGHL, Natasha, WIERZBICKI, Rafal, CINIERI, Saverio, ALAM, Yasmin, SIENA, Salvatore, TORTORA, Giampaolo, FELLETTI, Raffaella, RICCARDI, Ferdinando, MANCUSO, Gianfranco, ROSSI, Antonio, GALLO, Ciro, CANTILE, Flavia, TSAO, Ming-Sound, SAIEG, Mauro, DA CUNHA SANTOS, Gilda, PICCIRILLO, Maria Carmela, DI MAIO, Massimo, MORABITO, Alessandro, PERRONE, Francesco, FELD, Ronald, BUTTS, Charles, GEBBIA, Vittorio, MAIONE, Paolo, MORGILLO, Floriana, GENESTRETI, Giovenzio, FAVARETTO, Adolfo

Volltext

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer von Pujol, Jean-Louis, Pirker, Robert, Lynch, Thomas J, Butts, Charles A, Rosell, Rafael, Shepherd, Frances A, Vansteenkiste, Johan, O’Byrne, Kenneth J, de Blas, Barbara, Heighway, Jim, von Heydebreck, Anja, Thatcher, Nick

Volltext

Adjuvant Therapy in Non‐Small Cell Lung Cancer: Current and Future Directions von Sangha, Randeep, Price, Julie, Butts, Charles A.

Volltext

Time to Mobility Is Associated With Pulmonary Complications in Patients With Spine Fractures von Jackson, Michael L., Thomas, Samuel C., Joyner, Matthew R., Hu, Mengjie, Larry Lee, Yann-Leei, Capasso, Thomas, Polite, Nathan M., Kinnard, Christopher M., Mbaka, Maryann I., Williams, Ashley, Simmons, Jon D., Butts, Charles C.

Volltext

Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada von Debieuvre, Didier, Juergens, Rosalyn A., Asselain, Bernard, Audigier-Valette, Clarisse, Auliac, Jean-Bernard, Barlesi, Fabrice, Benoit, Nicolas, Bombaron, Pierre, Butts, Charles A., Dixmier, Adrien, Gröschel, Andreas, Gutz, Sylvia, Labbé, Catherine, Moro-Sibilot, Denis, Pérol, Maurice, Raspaud, Christophe, Schumann, Christian, Juarez-Garcia, Ariadna, Lakhdari, Khalid, Pettersson, Filippa, Penrod, John R., Reynaud, Dorothee, Waldenberger, Daniela, Allan, Victoria, Sebastian, Martin

Volltext

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer von Winton, Timothy, Livingston, Robert, Johnson, David, Rigas, James, Johnston, Michael, Butts, Charles, Cormier, Yvon, Goss, Glenwood, Inculet, Richard, Vallieres, Eric, Fry, Willard, Bethune, Drew, Ayoub, Joseph, Ding, Keyue, Seymour, Lesley, Graham, Barbara, Tsao, Ming-Sound, Gandara, David, Kesler, Kenneth, Demmy, Todd, Shepherd, Frances

Volltext

Identifying Radiographic and Clinical Indicators to Reduce the Occurrence of Nontherapeutic Laparotomy for Blunt Bowel and Mesenteric Injury von Blackley, Shem K., Smith, William C., Lee, Yann-Leei, Kinnard, Christopher, Williams, Ashley Y., Butts, Charles C., Mbaka, Maryann I., Haiflich, Andrew, Bright, Andrew, Simmons, Jon D., Polite, Nathan M.

Volltext

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a... von Tokito, Takaaki, Kolesnik, Oleksii, Sørensen, Jens, Artac, Mehmet, Quintela, Martín Lázaro, Lee, Jong-Seok, Hussein, Maen, Pless, Miklos, Paz-Ares, Luis, Leopold, Lance, Daniel, Jeannie, Munteanu, Mihaela, Samkari, Ayman, Xu, Lu, Butts, Charles

Volltext

Monotherapy Antibiotic Prophylaxis of Lower Extremity Long Bone Type III Open Fractures von Robinson, Thomas W., Gautreaux, Corinne E., Lee, Yann-Leei L., Mbaka, Maryann, Kinnard, Christopher M., Bright, Andrew C., Williams, Ashley Y., Polite, Nathan M., Capasso, Thomas J., Simmons, Jon D., Butts, Charles C.

Volltext

Incidence and Severity of Medication Reconciliation Discrepancies in Trauma Patients von Dunbar, Elisabeth G., Massey, Ashley C., Lee, Yannlei L., Mbaka, Maryann, Kinnard, Christopher M., Bright, Andrew C., Williams, Ashley Y., Polite, Nathan M., Simmons, Jon D., Butts, Charles C.

Volltext

Social Determinants of Health Impact Physical Recovery After Blunt Injury von Cockrell, Benjamin E., Haiflich, Andrew N., Lee, Yann-Leei L., Kinnard, Christopher M., Butts, Charles C., Polite, Nathan M., Mbaka, Maryann I., Bright, Andrew C., Simmons, Jon D., Williams, Ashley Y.

Volltext